Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e194. doi: 10.1111/jdv.13936. Epub 2016 Sep 16.

Authors

M M Hatch¹, Z Nawas², R Kollipara³, S K Tyring⁴

Affiliations

¹ Texas Tech University Health Sciences Center, Lubbock, TX, USA.
² Center for Clinical Studies, Houston, TX, USA.
³ Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
⁴ Department of Dermatology, The University of Texas Health Sciences Center at Houston, Houston, TX, USA.

PMID: 27550066
DOI: 10.1111/jdv.13936

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / therapeutic use*
Biopsy
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Male
Middle Aged
Porphyria Cutanea Tarda / complications
Porphyria Cutanea Tarda / diagnosis
Porphyria Cutanea Tarda / drug therapy*
Skin / pathology
Treatment Outcome

Substances

Antiviral Agents